Open AccessSarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2
Author(s) -
Hèctor Corominas,
Iván Castellví,
Cèsar Díaz-Torné,
Laia Matas,
David de la Rosa,
María Antònia Mangues,
Patricia Moya,
Virginia Pomar,
Natividad Benito,
Ester Moga,
Nerea Hernández-de Sosa,
Jordi Casademont,
Peré Domingo
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025923
Subject(s) - medicine , cytokine release syndrome , covid-19 , antagonist , cytokine storm , systemic inflammatory response syndrome , cytokine , immunology , sepsis , receptor , disease , infectious disease (medical specialty)